CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter from Hurricane Helene’s disruption.
Baxter to restart second IV fluid production line at hurricane-damaged site Read More »
The shocking failure of AbbVie’s emraclidine has investors questioning the Big Pharma’s long-term neuroscience strategy, which put the drug at the center of expectations.
AbbVie Shares Plummet 12% as Cerevel Schizophrenia Asset Fails Phase II Trials Read More »
The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana merger earlier this fall.
Cigna confirms it is not pursuing Humana acquisition Read More »
In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
RAPT Crashes After Axing Atopic Dermatitis, Asthma Hopeful, Cites Liver Injury Read More »
The deal, along with the Ohio-based health system’s current cash, would eliminate nearly all of Summa’s debt.
General Catalyst’s HATCo to acquire Summa Health for $485 million Read More »
Los antibióticos han salvado millones de vidas de las enfermedades infecciosas, siendo considerados uno de los descubrimientos más relevantes del siglo XX. Sin embargo, el uso (y abuso) creciente de los antibióticos a lo largo de todos estos años ha llevado a que muchas b …
Histonas para frenar las infecciones bacterianas Read More »
Se ha alcanzado un hito importante con el inicio de las pruebas de motor que propulsará el silencioso avión supersónico experimental X-59 de la NASA. Estas pruebas de arranque del motor, que comenzaron el 30 de octubre, permiten al equipo del X-59 verificar el funcionam …
El avión supersónico silencioso X-59 enciende su motor por primera vez Read More »
GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug price negotiation program.
GSK Quits Trade Group BIO as Industry Faces Uncertain Political Future Read More »
The companies did not provide detailed data for Tezspire, however, and William Blair’s Matt Phipps said in a note he does not expect the antibody to outperform Dupixent.
Unos científicos han puesto a punto un nuevo método para detectar la basura de plástico en las playas y lo han probado con éxito en un remoto tramo de costa. El trabajo lo ha realizado un equipo encabezado por Jenna Guffogg, de la Universidad RMIT en Australia. …
El plástico de las playas ya puede verse desde el espacio Read More »
